GT Biopharma, Inc. (GTBP)
0.7242
-0.02
(-2.90%)
USD |
NASDAQ |
Jan 20, 13:32
GT Biopharma Market Cap: 7.703M for Jan. 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| SELLAS Life Sciences Group, Inc. | 706.67M |
| Lyell Immunopharma, Inc. | 353.62M |
| Geron Corp. | 842.63M |
| Regeneron Pharmaceuticals, Inc. | 77.56B |
| Xencor, Inc. | 904.77M |
Market Cap Related Metrics
| Price to Book Value | 2.568 |
| Price | 0.7242 |
| Earnings Yield | -468.8% |